Strikingly, TRIP12 depletion strongly sensitized FBW7 wild type ovarian cancer cells whereas FBW7R505L mutant cell line was resistant to Taxol treatment regardless of TRIP12 status (Figure 6A–C). The gene discussed is TRIP12; the disease is ovarian carcinoma.